Covered recipient · General Payments record
MIKAELA D RUSH
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$10,187.94
- Reported across 142 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $476.25 | 14 |
| Education | $13.35 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $154.31 | 2 |
| Medtronic, Inc. | $88.22 | 2 |
| Astellas Pharma US Inc | $80.95 | 4 |
| SHIELD THERAPEUTICS INC | $66.57 | 1 |
| Biogen, Inc. | $34.22 | 2 |
| Evofem Biosciences, Inc. | $19.18 | 1 |
| Exeltis, USA Inc. | $17.01 | 1 |
| Channel Medsystems, Inc. | $15.79 | 1 |
| MILLICENT US INC | $13.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $125.91 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105989529 | CMS |
| ABBVIE INC. | $28.40 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105989531 | CMS |
| Astellas Pharma US Inc | $29.44 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139317282 | CMS |
| Astellas Pharma US Inc | $20.04 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139368893 | CMS |
| Astellas Pharma US Inc | $16.74 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139384032 | CMS |
| Astellas Pharma US Inc | $14.73 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139415333 | CMS |
| Biogen, Inc. | $16.72 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104870778 | CMS |
| Biogen, Inc. | $17.50 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104846736 | CMS |
| Channel Medsystems, Inc. | $15.79 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067444818 | CMS |
| Evofem Biosciences, Inc. | $19.18 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091286647 | CMS |
| Exeltis, USA Inc. | $17.01 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150003550 | CMS |
| Medtronic, Inc. | $48.12 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117062699 | CMS |
| Medtronic, Inc. | $40.10 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117062701 | CMS |
| MILLICENT US INC | $13.35 | 08/12/2024 | Education | Undisputed | 01/23/2026 | 1150911588 | CMS |
| SHIELD THERAPEUTICS INC | $66.57 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150144890 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.